These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30723410)

  • 1. A Guide to PIN1 Function and Mutations Across Cancers.
    El Boustani M; De Stefano L; Caligiuri I; Mouawad N; Granchi C; Canzonieri V; Tuccinardi T; Giordano A; Rizzolio F
    Front Pharmacol; 2018; 9():1477. PubMed ID: 30723410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Multiple Roles of Peptidyl Prolyl Isomerases in Brain Cancer.
    Stifani S
    Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30314361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation-Dependent Pin1 Isomerization of ATR: Its Role in Regulating ATR's Anti-apoptotic Function at Mitochondria, and the Implications in Cancer.
    Makinwa Y; Musich PR; Zou Y
    Front Cell Dev Biol; 2020; 8():281. PubMed ID: 32426354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition.
    Schutkowski M; Bernhardt A; Zhou XZ; Shen M; Reimer U; Rahfeld JU; Lu KP; Fischer G
    Biochemistry; 1998 Apr; 37(16):5566-75. PubMed ID: 9548941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis.
    Rippmann JF; Hobbie S; Daiber C; Guilliard B; Bauer M; Birk J; Nar H; Garin-Chesa P; Rettig WJ; Schnapp A
    Cell Growth Differ; 2000 Jul; 11(7):409-16. PubMed ID: 10939594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
    Ryo A; Liou YC; Lu KP; Wulf G
    J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic insights into Pin1 peptidyl-prolyl cis-trans isomerization from umbrella sampling simulations.
    Di Martino GP; Masetti M; Cavalli A; Recanatini M
    Proteins; 2014 Nov; 82(11):2943-56. PubMed ID: 25066180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Alternative Pin1 Binding and Isomerization Site in the N-Terminus Domain of PSD-95.
    Delgado JY
    Front Mol Neurosci; 2020; 13():31. PubMed ID: 32256312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular disease.
    Rostam MA; Piva TJ; Rezaei HB; Kamato D; Little PJ; Zheng W; Osman N
    Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):117-24. PubMed ID: 25377120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity.
    Ieda N; Itoh K; Inoue Y; Izumiya Y; Kawaguchi M; Miyata N; Nakagawa H
    Bioorg Med Chem Lett; 2019 Feb; 29(3):353-356. PubMed ID: 30585173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual Roles of Pin1 in Cancer Development and Progression.
    Han HJ; Choi BY; Surh YJ
    Curr Pharm Des; 2017 Nov; 23(29):4422-4425. PubMed ID: 28671058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer.
    Khanal P; Kim G; Lim SC; Yun HJ; Lee KY; Choi HK; Choi HS
    FASEB J; 2013 Nov; 27(11):4606-18. PubMed ID: 23934277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Pin1 in the development and treatment of cancer.
    Min SH; Zhou XZ; Lu KP
    Arch Pharm Res; 2016 Dec; 39(12):1609-1620. PubMed ID: 27572155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhein exhibits antitumorigenic effects by interfering with the interaction between prolyl isomerase Pin1 and c-Jun.
    Cho JH; Chae JI; Shim JH
    Oncol Rep; 2017 Mar; 37(3):1865-1872. PubMed ID: 28184937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pin1: a multi-talented peptidyl prolyl cis-trans isomerase and a promising therapeutic target for human cancers].
    Marsolier J; Weitzman JB
    Med Sci (Paris); 2014; 30(8-9):772-8. PubMed ID: 25174754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent advances in the study of pin1 and its inhibitors].
    Zhang CJ; Zhang ZH; Xu BL; Wang YL
    Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolyl Isomerase Pin1 in Human Cancer: Function, Mechanism, and Significance.
    Pu W; Zheng Y; Peng Y
    Front Cell Dev Biol; 2020; 8():168. PubMed ID: 32296699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminum(III) interferes with the structure and the activity of the peptidyl-prolyl cis-trans isomerase (Pin1): a new mechanism contributing to the pathogenesis of Alzheimer's disease and cancers?
    Wang JZ; Liu J; Lin T; Han YG; Luo Y; Xi L; Du LF
    J Inorg Biochem; 2013 Sep; 126():111-7. PubMed ID: 23806774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of PIN1 in Cancer Development and Its Inhibitors as Cancer Therapeutics.
    Yu JH; Im CY; Min SH
    Front Cell Dev Biol; 2020; 8():120. PubMed ID: 32258027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gears-In-Motion: The Interplay of WW and PPIase Domains in Pin1.
    Lee YM; Liou YC
    Front Oncol; 2018; 8():469. PubMed ID: 30460195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.